Coloplast A/S (OTCPK:CLPBF) Q1 2025 Results Conference Call February 4, 2025 5:00 AM ET Company Participants Kristian Villumsen - Chief Executive Officer Anders Lonning-Skovgaard - Chief Financial Off
2024/25 Interim financial results, Q1 2024/25 1 October 2024 - 31 December 2024 Coloplast delivered 8% organic growth and an EBIT margin1 of 27% in Q1, in line with expectations. Reported revenue in

Coloplast A/S - Allocation of Share Options

07:12am, Tuesday, 04'th Feb 2025
Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactio
Tuesday, 4 February 2025 at 10.00 - 11.00am CET In connection with the publication of Coloplast's interim financial results for Q1 2024/25, to be released same day around 07.30am CET, Coloplast will h
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons.
Today, 5 December 2024, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2023/24 was approved. Distribution of y
Coloplast A/S (OTCPK:CLPBF) Q4 2024 Earnings Conference Call November 5, 2024 5:00 AM ET Company Participants Nicholas Seibert - Vice President of Corporate Development & Investor Relations Kristian V
Tuesday, 5 November 2024 at 11.00 – 12.00 CET In connection with the publication of Coloplast's interim financial results for FY 2023/24 the company will host a conference call to present the financ
Please see enclosed pdf.   Attachment 25092024_trading_in_shares_N_P_Louis-Hansen_ApS

Coloplast A/S - Financial Calendar 2024-25

08:29am, Wednesday, 25'th Sep 2024
Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://investor.coloplast.com/investor-relations/financial-calendar-and-events/ Kind regards
Please see enclosed pdf.   Attachment 03092024_trading_in_shares_ASL
Please see enclosed pdf.   Attachment 03092024_trading_in_shares_NAN
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons.
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons.
If you are looking for stocks that are well positioned to maintain their recent uptrend, Coloplast A/S Sponsored ADR (CLPBY) could be a great choice. It is one of the several stocks that passed throug
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE